For Narrow Networks, Fresh Scrutiny: Can They Pass the Adequacy Test?
Health Insurers Struggle to Manage Number, Cost of Genetic Tests
Effect of Removing Financial Barriers on Use of Long-acting Reversible Contraceptives
Randy Vogenberg, PhD: The differences among the latest diabetes medications are seen as less than dramatic, creating questions about the costs and benefits of the various new treatment options. Meanwhile, patient compliance remains a concern.